Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
6.55
+0.41 (6.68%)
At close: Apr 2, 2026, 4:00 PM EDT
6.54
-0.01 (-0.17%)
After-hours: Apr 2, 2026, 4:32 PM EDT
Tilray Brands Market Cap
Tilray Brands has a market cap or net worth of $763.12 million as of April 2, 2026. Its market cap has increased by 20.45% in one year.
Market Cap
763.12M
Enterprise Value
780.71M
1-Year Change
20.45%
Ranking
Category
Stock Price
$6.55
Market Cap Chart
Since May 4, 2021, Tilray Brands's market cap has decreased from $9.87B to $763.12M, a decrease of -92.27%. That is a compound annual growth rate of -40.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 715.35M | -31.52% |
| Dec 31, 2025 | 1.04B | -13.05% |
| Dec 31, 2024 | 1.20B | -28.47% |
| Dec 29, 2023 | 1.68B | 2.13% |
| Dec 30, 2022 | 1.64B | -63.52% |
| Dec 31, 2021 | 4.51B | -54.31% |
| May 4, 2021 | 9.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.06B |
| Cronos Group | 949.79M |
| Pacira BioSciences | 922.76M |
| Amphastar Pharmaceuticals | 918.29M |
| Evotec SE | 917.70M |
| BioAge Labs | 786.85M |
| Eton Pharmaceuticals | 691.93M |
| Esperion Therapeutics | 670.28M |